Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective

The treatment of multiple myeloma (MM) has undergone significant developments in recent years. The availability of the novel agents thalidomide, bortezomib, and lenalidomide has expanded treatment options and has improved the outcome of patients with MM. Following the introduction of these agents in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Boccadoro, Mario, Cavenagh, Jamie, Cavo, Michele, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Ketterer, Nicolas, Kropff, Martin, Mendeleeva, Larisa, Morgan, Gareth, Palumbo, Antonio, Plesner, Torben, San Miguel, Jesús, Shpilberg, Ofer, Sondergeld, Pia, Sonneveld, Pieter, Zweegman, Sonja
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2010
Schlagworte:
Academia–Pharma Intersect
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227886/
https://ncbi.nlm.nih.gov/pubmed/20086168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0203
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge